Sleeve gastrectomy is a commonly performed bariatric procedure that is complicated by stricture formation in approximately 0.5% of cases. 1 Gastric sleeve surgery adverse events, which can result in strictures and leaks, are increasingly managed through a minimally invasive endoscopic approach. Surgical revision of sleeve gastrectomy is associated with significant morbidity even when performed laparoscopically. 2, 3 Therefore, endoscopic management is the preferred option. However, the usual endoscopic management of strictures with balloon dilation and covered esophageal stents is not always successful and may require a repeated operation. We present a new endoscopic option for the management of gastric sleeve strictures refractory to usual endoscopic management.
CASE REPORT
A 43-year-old woman underwent laparoscopic sleeve gastrectomy at another hospital; the gastrectomy was complicated by a leak and stricture formation in the sleeve. She had postoperative abdominal pain and intolerance of oral intake. A CT scan performed 1 month after surgery revealed a 3.7 cm Â 1.5 cm perigastric fluid collection, but she did not have fever or leukocytosis to suggest a superimposed infection. An EGD was performed with attempted placement of a 20 mm Â 120 mm esophageal stent across the gastric sleeve stricture. However, she remained intolerant of oral intake, even liquids. An upper GI series revealed complete obstruction caused by a stricture in the gastric sleeve ( Fig. 1 ) with no passage of contrast medium past the stricture.
She was then referred to our institution for further treatment. An EGD was performed with removal of the previously placed esophageal stent, which was located entirely proximal to the gastric stricture. The gastric sleeve stricture resulted in a very acute angulation of the gastric lumen, which was narrowed to 3 mm (Fig. 2) . A guidewire was placed across the stricture under fluoroscopic guidance, and a catheter was advanced through the stricture (Fig. 3) . Injection of contrast medium revealed a highgrade short 1-cm stricture in the distal aspect of the sleeve. The stricture was dilated to 12 mm by use of a continuous radial expansion (CRE) balloon (Fig. 3) , and the patient was able to tolerate a pureed diet. A repeated dilation was performed 2 weeks later, but she continued to have difficulty with solid food intake and occasional vomiting. Repeated EGD confirmed that the pylorus was located 1 to 2 cm distal to the stricture, which was 1 cm long. Given the proximity of the pylorus to the stricture, a fully covered esophageal stent could not be deployed across the stricture without migrating proximally. Therefore, a 15 mm Â 10 mm fully covered lumen-apposing metal stent (LAMS) (AXIOS, Boston Scientific, Natick, Mass) was deployed successfully across the stricture under fluoroscopic and endoscopic guidance (Figs. 4 and 5; Video 1, available online at www. VideoGIE.org). The stent was dilated to 13.5 mm by use of a controlled radial expansion balloon. The patient noted significant, immediate improvement in her oral intake and was able to tolerate a soft diet. Her weight remained stable after stent placement. The LAMS was removed 3 months later without difficulty by use of a rat-tooth forceps and revealed excellent dilation of the stricture (Fig. 6) . In addition, the angulation of the gastric sleeve was also much improved. The patient has had no recurrent problems with oral intake to date and remains well.
DISCUSSION
In patients for whom balloon dilation and fully covered esophageal stent management has been unsuccessful, further management often involves surgical revision, including conversion to Roux-en-Y gastric bypass. Our case report provides an alternative treatment option. Gastric sleeve strictures are often focal and short in nature, as are most postsurgical strictures. The shape of the lumenapposing stent offers protection against stent migration, which allows the stent to remain for a longer time without concern over stent migration, which can occur with straighter covered esophageal stents. We were able to leave the LAMS in place for 3 months, which allowed remodeling of the gastric sleeve around the stent, resulting in a more durable dilation over time. Although the LAMS is more costly than esophageal stents, it may result in fewer endoscopic procedures and avoidance of surgery, which ultimately may result in cost savings. Here we report the novel use of a LAMS in the setting of a gastric sleeve stricture, and further experience may confirm this to be an effective treatment option of gastric sleeve strictures.
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